In the last 12 months, insiders at AtaiBeckley Inc. ($ATAI) filed 31 transactions with the SEC: 0 open-market purchases totaling $0 and 3 sales totaling $722,272. Net insider sentiment: net selling.
AtaiBeckley Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Angermayer Christian (Not found) — 6 transactions totaling $897,297
- Craig Kevin James (Chief Medical Officer) — 12 transactions totaling $762,573
- Feilding-Mellen Cosmo (Not found) — 1 transaction totaling $154,377
- Short Glenn Frank (Chief Scientific Officer) — 2 transactions totaling $0
- Johnson Anne Nagengast (Chief Financial Officer) — 2 transactions totaling $0
View all SEC Filings for AtaiBeckley Inc. (ATAI).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 20, 2026 | Craig Kevin James | Chief Medical Officer | M | Stock Option | 15299 | $0.00 | 372,701.0000 | 226,532,786 | 3.94% | 0.01% |
| April 20, 2026 | Craig Kevin James | Chief Medical Officer | M | Stock Option | 27280 | $0.00 | 706,859.0000 | 226,532,786 | 3.72% | 0.01% |
| April 20, 2026 | Craig Kevin James | Chief Medical Officer | S | Common Stock | 42579 | $5.00 | 8,437.0000 | 226,532,786 | 83.46% | 0.02% |
| April 20, 2026 | Craig Kevin James | Chief Medical Officer | M | Common Stock | 15299 | $1.84 | 51,016.0000 | 226,532,786 | 42.83% | 0.01% |
| April 20, 2026 | Craig Kevin James | Chief Medical Officer | M | Common Stock | 27280 | $1.50 | 35,717.0000 | 226,532,786 | 323.34% | 0.01% |
| April 8, 2026 | Angermayer Christian | Not found | M | Stock Option | 103000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 8, 2026 | Angermayer Christian | Not found | M | Common Stock | 46070 | $1.88 | 55,257,786.0000 | 0 | 0.08% | 0.00% |
| April 8, 2026 | Angermayer Christian | Not found | M | Common Stock | 410162 | $1.64 | 55,667,948.0000 | 0 | 0.74% | 0.00% |
| April 8, 2026 | Angermayer Christian | Not found | M | Common Stock | 103000 | $1.34 | 55,770,948.0000 | 0 | 0.19% | 0.00% |
| April 8, 2026 | Angermayer Christian | Not found | M | Stock Option | 46070 | $0.00 | 17,930.0000 | 0 | 71.98% | 0.00% |
| April 8, 2026 | Angermayer Christian | Not found | M | Stock Option | 410162 | $0.00 | 231,838.0000 | 0 | 63.89% | 0.00% |
| March 20, 2026 | Craig Kevin James | Chief Medical Officer | M | Stock Option | 76224 | $0.00 | 38,136.0000 | 0 | 66.65% | 0.00% |
| March 20, 2026 | Craig Kevin James | Chief Medical Officer | M | Stock Option | 23776 | $0.00 | 734,139.0000 | 0 | 3.14% | 0.00% |
| March 20, 2026 | Craig Kevin James | Chief Medical Officer | M | Common Stock | 76224 | $1.18 | 84,661.0000 | 0 | 903.45% | 0.00% |
| March 20, 2026 | Craig Kevin James | Chief Medical Officer | M | Common Stock | 23776 | $1.50 | 108,437.0000 | 0 | 28.08% | 0.00% |
| March 20, 2026 | Craig Kevin James | Chief Medical Officer | S | Common Stock | 100000 | $3.55 | 8,437.0000 | 0 | 92.22% | 0.00% |
| March 11, 2026 | Faerm Michael E. | Chief Financial Officer | A | Stock Option | 1275000 | $0.00 | 1,275,000.0000 | 0 | 9999.99% | 0.00% |
| March 11, 2026 | Faerm Michael E. | Chief Financial Officer | A | Restricted Stock Units | 285000 | $0.00 | 285,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Barrett Christopher Ryan Cave | See remarks | A | Stock Option | 675000 | $0.00 | 675,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Rao Srinivas | See remarks | A | Stock Option | 1988000 | $0.00 | 1,988,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Rao Srinivas | See remarks | A | Restricted Stock Units | 442000 | $0.00 | 442,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Short Glenn Frank | Chief Scientific Officer | A | Stock Option | 675000 | $0.00 | 675,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Short Glenn Frank | Chief Scientific Officer | A | Restricted Stock Units | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Craig Kevin James | Chief Medical Officer | A | Stock Option | 675000 | $0.00 | 675,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Craig Kevin James | Chief Medical Officer | A | Restricted Stock Units | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Kochendoerfer Gerd | Chief Operating Officer | A | Restricted Stock Units | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Kochendoerfer Gerd | Chief Operating Officer | A | Stock Option | 675000 | $0.00 | 675,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Johnson Anne Nagengast | Chief Financial Officer | A | Restricted Stock Units | 117000 | $0.00 | 117,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Johnson Anne Nagengast | Chief Financial Officer | A | Stock Option | 525000 | $0.00 | 525,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Barrett Christopher Ryan Cave | See remarks | A | Restricted Stock Units | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2026 | Feilding-Mellen Cosmo | Not found | S | Common Stock | 39594 | $3.90 | 7,663,396.0000 | 0 | 0.51% | 0.00% |